ANAL CANAL SQUAMOUS CELL CARCINOMA
Clinical trials for ANAL CANAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL CANAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL CANAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? new study tests gentler treatment for anal cancer
Disease control OngoingThis study looks at whether a lower dose of chemotherapy plus radiation can control early-stage anal cancer as well as the standard higher dose, while causing fewer side effects. About 252 adults with small tumors (4 cm or less) that haven't spread will take part. The goal is to …
Matched conditions: ANAL CANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Immunotherapy combo shows promise for tough anal cancer
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab alone or with ipilimumab, in people with anal cancer that has spread and not improved after other treatments. The goal is to see if these drugs can shrink tumors or slow the cancer's growth. About 143 adults with this type of ca…
Matched conditions: ANAL CANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New study tracks Cancer's genetic shifts during therapy
Knowledge-focused OngoingThis study looks at how squamous cell cancers of the head and neck, esophagus, and anal canal change at the genetic and immune level during chemotherapy or immunotherapy. About 39 adults with recurrent or metastatic disease will provide blood samples and tumor tissue before and d…
Matched conditions: ANAL CANAL SQUAMOUS CELL CARCINOMA
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 17, 2026 12:46 UTC